Delivery Order SPE2DR25D2006-SPE2DR26F57MS
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,930.88 to AmerisourceBergen Drug Corp for the supply of Adderall tablets (30mg) on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and...
- The Defense Logistics Agency awarded a delivery order valued at $13,604.46 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is to be fulfilled at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,048.85 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed-price contract. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of December 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.66 to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100-count units) with an ultimate completion date of January 16, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $3,676.98 for Adderall 30mg tablets (100 count) on January 20, 2026, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which operates under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,266.54 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and carries an ultimate completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,713,966 units of Adderall 5 mg tablets. The $14,800.73 contract has a completion date of February 21, 2024 and was awarded on February 20, 2024. Amerisourcebergen Drug Corp is a for-profit prime contractor that provides pharmaceutical products and medical supplies to DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $27,717.80 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units) on January 16, 2026, with an ultimate completion date of January 20, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed-price contract valued at $23,466.37, with an ultimate completion date of December 9, 2025. This competitively awarded, non-set-aside delivery order supports the federal government's pharmaceutical supply needs for military and related healthcare systems. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $5,032.66 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) with a firm fixed price structure. The contract is non-competitive with no set-aside designation and carries an ultimate completion date of December 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57MSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,111.69 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) with a completion deadline of January 22, 2026. This is a firm fixed-price, non-set-aside contract awarded on January 21, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The contract reflects the contractor's demonstrated capability to meet federal procurement requirements through open competition and aligns with DLA's strategy to maintain robust pharmaceutical supply chains for the Department of Defense and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 1/20/26 |